| September 20, 2010: Cardiovascular and Renal Drugs Advisory Committee Meeting ... - Bioscience Technology |
|
|
Bioscience TechnologyBy Federal Drug Administration Friday, August 27, 2010 The committee will discuss new drug application (NDA) 22–512, dabigatran etexilate mesylate capsules, ... read more |